These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 22104981

  • 1. Efficacy and tolerability of armodafinil: effect on clinical condition late in the shift and overall functioning of patients with excessive sleepiness associated with shift work disorder.
    Erman MK, Seiden DJ, Yang R, Dammerman R.
    J Occup Environ Med; 2011 Dec; 53(12):1460-5. PubMed ID: 22104981
    [Abstract] [Full Text] [Related]

  • 2. The impact of shift duration on the efficacy and tolerability of armodafinil in patients with excessive sleepiness associated with shift work disorder.
    Harsh J, Yang R, Hull SG.
    Curr Med Res Opin; 2014 May; 30(5):945-51. PubMed ID: 24450538
    [Abstract] [Full Text] [Related]

  • 3. Armodafinil for treatment of excessive sleepiness associated with shift work disorder: a randomized controlled study.
    Czeisler CA, Walsh JK, Wesnes KA, Arora S, Roth T.
    Mayo Clin Proc; 2009 Nov; 84(11):958-72. PubMed ID: 19880686
    [Abstract] [Full Text] [Related]

  • 4. A double-blind, placebo-controlled study of armodafinil for excessive sleepiness in patients with treated obstructive sleep apnea and comorbid depression.
    Krystal AD, Harsh JR, Yang R, Rippon GA, Lankford DA.
    J Clin Psychiatry; 2010 Jan; 71(1):32-40. PubMed ID: 20051221
    [Abstract] [Full Text] [Related]

  • 5. Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults.
    Roth T, White D, Schmidt-Nowara W, Wesnes KA, Niebler G, Arora S, Black J.
    Clin Ther; 2006 May; 28(5):689-706. PubMed ID: 16861091
    [Abstract] [Full Text] [Related]

  • 6. Tolerability and efficacy of armodafinil in naïve patients with excessive sleepiness associated with obstructive sleep apnea, shift work disorder, or narcolepsy: a 12-month, open-label, flexible-dose study with an extension period.
    Schwartz JR, Khan A, McCall WV, Weintraub J, Tiller J.
    J Clin Sleep Med; 2010 Oct 15; 6(5):450-7. PubMed ID: 20957845
    [Abstract] [Full Text] [Related]

  • 7. Armodafinil improves wakefulness and long-term episodic memory in nCPAP-adherent patients with excessive sleepiness associated with obstructive sleep apnea.
    Roth T, Rippon GA, Arora S.
    Sleep Breath; 2008 Mar 15; 12(1):53-62. PubMed ID: 17874255
    [Abstract] [Full Text] [Related]

  • 8. The long-term tolerability and efficacy of armodafinil in patients with excessive sleepiness associated with treated obstructive sleep apnea, shift work disorder, or narcolepsy: an open-label extension study.
    Black JE, Hull SG, Tiller J, Yang R, Harsh JR.
    J Clin Sleep Med; 2010 Oct 15; 6(5):458-66. PubMed ID: 20957846
    [Abstract] [Full Text] [Related]

  • 9. The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy.
    Harsh JR, Hayduk R, Rosenberg R, Wesnes KA, Walsh JK, Arora S, Niebler GE, Roth T.
    Curr Med Res Opin; 2006 Apr 15; 22(4):761-74. PubMed ID: 16684437
    [Abstract] [Full Text] [Related]

  • 10. Adjunct armodafinil improves wakefulness and memory in obstructive sleep apnea/hypopnea syndrome.
    Hirshkowitz M, Black JE, Wesnes K, Niebler G, Arora S, Roth T.
    Respir Med; 2007 Mar 15; 101(3):616-27. PubMed ID: 16908126
    [Abstract] [Full Text] [Related]

  • 11. Effects of armodafinil on simulated driving and alertness in shift work disorder.
    Drake C, Gumenyuk V, Roth T, Howard R.
    Sleep; 2014 Dec 01; 37(12):1987-94. PubMed ID: 25325498
    [Abstract] [Full Text] [Related]

  • 12. The effects of armodafinil on objective sleepiness and performance in a shift work disorder sample unselected for objective sleepiness.
    Howard R, Roth T, Drake CL.
    J Clin Psychopharmacol; 2014 Jun 01; 34(3):369-73. PubMed ID: 24717254
    [Abstract] [Full Text] [Related]

  • 13. Armodafinil.
    Garnock-Jones KP, Dhillon S, Scott LJ.
    CNS Drugs; 2009 Sep 01; 23(9):793-803. PubMed ID: 19689169
    [Abstract] [Full Text] [Related]

  • 14. Armodafinil in the treatment of excessive sleepiness.
    Bogan RK.
    Expert Opin Pharmacother; 2010 Apr 01; 11(6):993-1002. PubMed ID: 20307223
    [Abstract] [Full Text] [Related]

  • 15. Armodafinil for excessive daytime sleepiness.
    Nishino S, Okuro M.
    Drugs Today (Barc); 2008 Jun 01; 44(6):395-414. PubMed ID: 18596995
    [Abstract] [Full Text] [Related]

  • 16. Armodafinil for the treatment of excessive sleepiness associated with mild or moderate closed traumatic brain injury: a 12-week, randomized, double-blind study followed by a 12-month open-label extension.
    Menn SJ, Yang R, Lankford A.
    J Clin Sleep Med; 2014 Nov 15; 10(11):1181-91. PubMed ID: 25325609
    [Abstract] [Full Text] [Related]

  • 17. Modafinil for excessive sleepiness associated with shift-work sleep disorder.
    Czeisler CA, Walsh JK, Roth T, Hughes RJ, Wright KP, Kingsbury L, Arora S, Schwartz JR, Niebler GE, Dinges DF, U.S. Modafinil in Shift Work Sleep Disorder Study Group.
    N Engl J Med; 2005 Aug 04; 353(5):476-86. PubMed ID: 16079371
    [Abstract] [Full Text] [Related]

  • 18. Armodafinil and modafinil in patients with excessive sleepiness associated with shift work disorder: a pharmacokinetic/pharmacodynamic model for predicting and comparing their concentration-effect relationships.
    Darwish M, Bond M, Ezzet F.
    J Clin Pharmacol; 2012 Sep 04; 52(9):1328-42. PubMed ID: 22039290
    [Abstract] [Full Text] [Related]

  • 19. Armodafinil: a new treatment for excessive sleepiness.
    Lankford DA.
    Expert Opin Investig Drugs; 2008 Apr 04; 17(4):565-73. PubMed ID: 18363520
    [Abstract] [Full Text] [Related]

  • 20. The effect of armodafinil on patient-reported functioning and quality of life in patients with excessive sleepiness associated with shift work disorder: a randomized, double-blind, placebo-controlled trial.
    Erman MK, Yang R, Seiden DJ.
    Prim Care Companion CNS Disord; 2012 Apr 04; 14(4):. PubMed ID: 23251870
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.